301-251-6638
Contact Us
Request a Quote
About Us
Distributors
Careers
301-251-6638
Technical
Resources
Technical Resources
Citations & Testimonials
Order Support
FAQ
My Account
Log In
Create Account
My Cart
My Cart
1
MENU
MENU
Viral Packaging Services
AAV Packaging
Adenovirus Packaging
Lentivirus Packaging
Analytical Services
cGMP Services
cGMP AAV Production
cGMP Adenovirus Production
cGMP Lentivirus Production
cGMP Retrovirus Production
cGMP Custom Virus Production
Cell & Virus Banking
Aseptic Filling
Plasmid Manufacturing
cGMP QC Services
cGMP Process Development
IND/IMPD Services
Cloning Services
Molecular Cloning
Gene Synthesis & Mutagenesis
shRNA Cloning
CRISPR/Cas9 Cloning
Products
AAV Products
AAV Controls
AAV Biosensors
AAV Parkinson's Disease Tools
AAV Zika ORFs
Reference Standards
AAV Full Capsids
AAV Empty Capsids
Adenovirus Products
Adenovirus Controls
Adenovirus ORFs
Adenovirus miRNAs
Adenovirus Zika ORFs
Lentivirus Products
Lentivirus Controls
Lentivirus ORFs
Plasmid Products
Shuttle Vectors & Promoters
Plasmid ORFs
Plasmid miRNAs
Plasmid Zika ORFs
Plasmid shRNAs
GMP-Ready
TM
/GMP Plasmids
AAV pHelper-Kan
Technologies
Upstream
Downstream
Producer Cell Lines
Facilities
Home
News & Events
Vigene Biosciences
News & Events
Filter by
Categories
Tags
Authors
Show all
All
Blog
Press Releases
All
All
Supreme Retainer Team
Vigene Biosciences
Vigenebio Developer
November 3, 2020
Vigene Strengthens Management Team with Another Ke...
Vigene Biosciences announces today another key executive addition. Audrey Chang, Ph.D. is appointed as the VP of QC and Analytical Services.
October 12, 2020
Vigene Strengthens Management Team Critical Execut...
Vigene Biosciences announces today an executive addition. Molly McGlaughlin is appointed as Chief Operation Officer.
October 9, 2020
Rznomics Announces Manufacturing Agreement with Vi...
Vigene has entered a contract manufacturing agreement with Rznomics Inc. for its leading pipeline product, RZ-001. RZ-001 is a gene therapy for advanced hepatocellular carcinoma (HCC).
August 31, 2020
Vigene Biosciences made the 2020 Inc. 5000 list of...
Vigene Biosciences made the 2020 Inc. 5000 list of the fastest-growing private companies in America!
July 22, 2020
Altimmune Announces Manufacturing Agreement with V...
Vigene entered an agreement with Altimmune to manufacture its single-dose intranasal vaccine candidate for COVID-19.
June 4, 2020
Vigene Biosciences Awarded Patent for improvements...
The modifications on AAV vector leads to 2-4 folds increase in production yield.
May 5, 2020
Vigene’s Webinar Series on Viral Vector and ...
Join our monthly live webinars to interact with our scientists. Vigene's viral vector and plasmid production technology webinar series
March 27, 2020
Vigene Joins the Fight Against COVID-19 – M...
Vigene has joined the fight against COVID-19 by helping manufacture vaccines for COVID-19.
March 23, 2020
Vigene’s COVID-19 Update – March 23rd,...
We would like to update you on the precautions and actions that Vigene Biosciences is taking due to the rapidly
[…]
February 27, 2020
Maryland Biotech Opens New Gene Therapy Contract M...
BioBuzz reported on the grand opening of Vigene Biosciences’s new 51,000 square feet GMP manufacturing facility.
1
2
3
4
Next page